Genotoxic Effects of Amplitude-Modulated Microwaves on Human Lymphocytes Exposed in Vitro under Controlled Conditions

1995 ◽  
Vol 14 (3) ◽  
pp. 157-164 ◽  
Author(s):  
G. D'ambrosio ◽  
M. B. Lioi ◽  
R. Massa ◽  
M. R. Scarfi ◽  
O. Zeni
2009 ◽  
Vol 25 (3) ◽  
pp. 294-303 ◽  
Author(s):  
Gabriele Jovtchev ◽  
Svetla Gateva ◽  
Mila Stergios ◽  
Stanislava Kulekova

2008 ◽  
Vol 44 (5) ◽  
pp. 546-552
Author(s):  
V. Bajić ◽  
N. Djelić ◽  
B. Spremo-Potparević ◽  
L. Živković ◽  
Z. Milićević

2006 ◽  
Vol 61 (11-12) ◽  
pp. 903-910 ◽  
Author(s):  
Serap Çelikler ◽  
Rahmi Bilaloğlu ◽  
Nilüfer Aydemir

Abstract The aim of this study was to investigate the in vitro genotoxic effects of the anticancer drugs fotemustine and vinorelbine on human lymphocytes and to determine individual and sex-related responses to these drugs. Fotemustine is a DNA-alkylating drug while vinorelbine is a semi-synthetic Vinca alkaloid. The study was carried out with twenty independent healthy donors for each drug. We have tested the ability of these drugs to induce chromosome aberrations (CAs) and sister chromatid exchanges (SCEs) as well as effect on the mitotic index (MI) in cultured human lymphocytes. Fotemustine was shown to induce CAs and SCEs at all concentrations tested (2, 4 and 8 μg/ml) in a dose-dependent manner. Additionally it also decreased the mitotic index in a similar dose-dependent manner. Vinorelbine had no effect on structural CAs, but it significantly increased the numerical CAs at all doses tested (0.5, 1 and 2 μg/ml). Vinorelbine also induced SCE events and increased the MI values. Two-way analyses of variance were used to compare the individual and gender-related susceptibilities to fotemustine and vinorelbine with respect to the CA, SCE and MI values. The results indicated that individuals in fotemustine treatment groups showed different genotoxic responses with respect to CA and SCE induction and additional findings indicated a gender-specific response in this group. Individuals in the vinorelbine test group also exhibited statistically significant numerical CA, SCE and MI responses to vinorelbine. A statistically significant gender-related SCE response to this drug was also evident. This study indicates that these drugs have potentially harmful effects on human health.


1989 ◽  
Vol 225 (1-2) ◽  
pp. 11-14 ◽  
Author(s):  
Daniele Decuyper-Debergh ◽  
Jacques Piette ◽  
Christian Laurent ◽  
Albert van de Vorst

Genetika ◽  
2017 ◽  
Vol 49 (2) ◽  
pp. 387-397
Author(s):  
Jasna Bosnjak-Neumüller ◽  
Ninoslav Djelic ◽  
Milena Radakovic ◽  
Stoimir Kolarevic ◽  
Dragana Mitic-Culafic ◽  
...  

There is increasing evidence that substances which are normally present in human or animal bodies may, under the certain circumstances, exhibit deleterious effects on genetic material, therefore acting as endogenous mutagenic agents. Since hormones represent one of the best studied endogenous mutagens, some research focused on the possible role of thyroid hormone in mutagenesis and carcinogenesis. Indeed, thyroid hormones accelerate aerobic metabolism and production of reactive oxygen species (ROS) and, therefore, may exhibit mutagenic effects in various test systems on mammalian cells. However, possible mutagenic effects on prokaryotic DNA has not been investigated so far. Hence, the aim of this research was to compare the sensitivity of TA 100 Salmonella typhimurium with and without metabolic activation with S9 fraction, and human lymphocytes to possible genotoxic effects of triiodothyronine (T3). Therefore, we used the reverse mutation assay on S. typhimurium (Ames test) and in vitro Comet assay in isolated peripheral blood human lymphocytes. In both tests-systems a broad spectrum of T3 concentrations was applied. The obtained results showed absence of genotoxic effects of T3 in bacterial reverse mutation assay and very profound genotoxic effects in human lymphocytes at concentrations higher than 15 ?M. We only observed cytotoxic effects in bacterial system at very high T3 concentrations (300 and 500 ?M). In conclusion, T3 was unable to increase the level of reverse mutations in Ames test both with and without S9 mix. Therefore, it seems that ROS production in mitochondria may be the primary cause of DNA damage caused by T3 in mammalian cells.


Author(s):  
Marúcia Irena Medeiros Amorim ◽  
Íris Ferrari ◽  
Marcelo de Oliveira Bahia ◽  
Patrícia Danielle Lima Lima ◽  
Plínio Cerqueira dos Santos Cardoso ◽  
...  

Mutagenesis ◽  
2013 ◽  
Vol 28 (6) ◽  
pp. 645-651 ◽  
Author(s):  
Evelyn Beristain-Castillo ◽  
Mariano Martínez-Vázquez ◽  
Rafael Camacho-Carranza ◽  
Javier J. Espinosa-Aguirre

Abstract Niclosamide produces genotoxic effects, such as point mutations in Salmonella sp., sperm-head abnormalities in mice and clastogenic effects in human lymphocytes in vitro and in vivo. As cytochrome P450 could be involved in the bioactivation of niclosamide, we investigated which subfamily was involved. We used liver microsomal fractions from rats treated with phenobarbital/β-naphthoflavone (PB/β-NF), benzo[a]pyrene (BaP) or cyclohexanol, which are known to induce different cytochrome P450 subfamilies, such as CYP2B, CYP1A1, CYP1A2 and CYP2E1. We also inhibited CYP1A and CYP2E using α-NF and diethyldithiocarbamate to identify the cytochrome P450 involved. Liver-S9 fractions obtained from PB/β-NF- and BaP-treated rats significantly increased the number of revertants induced by niclosamide, while the CYP1A1 inhibitor α-NF decreased the number of revertants. The incubation of niclosamide with CYP1A1 Supersomes™ increased the number of revertants, suggesting that CYP1A1 is responsible for the bioactivation of niclosamide. Nitroreduction is also involved in niclosamide bioactivation, as the nitroreductase-deficient strain YG7132 did not respond to the niclosamide treatment. Our findings indicated that a metabolite, derived from the action of CYP1A1 and a nitroreduction-reaction process, has a key role in the bioactivation of niclosamide.


Sign in / Sign up

Export Citation Format

Share Document